Liabilities / Assets
99th percentile
Higher debt load relative to assets than 99% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
99th percentile
Higher debt load relative to assets than 99% of similar nonprofits.
Liabilities / Revenue
98th percentile
Higher debt load relative to revenue than 98% of similar nonprofits.
Net Margin
2nd percentile
Higher net margin than 2% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
94th percentile
Faster asset growth than 94% of similar nonprofits.
Revenue Growth
98th percentile
Faster revenue growth than 98% of similar nonprofits.
Assets
Up$26,199
Up $16,199 (+162%) from 2013
Net Assets
-
No earlier filing loaded for comparison.
Liabilities
Up$151,414
Up $147,120 (+3426%) from 2013
Revenue
Up$46,568
Up $36,568 (+366%) from 2013
Expenses
Up$167,489
Up $163,195 (+3801%) from 2013
Net Income
Down-$120,921
Down $126,627 (-2219%) from 2013
This 2014 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
The primary purpose is to advance the validation and application of genetic markers that could lead to prevention and personalized medicine.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2014 • Form 990EZSummary only. Only limited summary data is available for this year.